<scp>CH50</scp> as a Clinically Useful Biomarker of Disease Activity and Antihistamine Resistance in Chronic Spontaneous Urticaria: An Observational Ambispective Single‐Center Study
CH50 is a novel and promising biomarker for antihistamine resistance in CSU, outperforming previously described markers. Its low cost and accessibility support integration into CSU stratification and endotype-driven therapeutic algorithms, pending validation in multicenter cohorts.
Authors
- R. Pujol
- David Pesqué (ORCID: https://orcid.org/0000-0002-5821-9780)
- Nidia Planella‐Fontanillas (ORCID: https://orcid.org/0009-0007-1303-2422)
- Fernando Gallardo (ORCID: https://orcid.org/0000-0002-8996-3828)
- Evelyn Andrades
- A. M. Giménez‐Arnau
- Silvia Sánchez
- Ramon Gimeno
- Paloma Torres‐Bosó
- Emilio Berna‐Rico
Institutions
- Universitat Autònoma de Barcelona (ES)
- Universitat Pompeu Fabra (ES)
- Instituto Ramón y Cajal de Investigación Sanitaria (ES)
- Hospital Del Mar (ES)
- Hospital Universitario Ramón y Cajal (ES)
Publication Details
- Journal
- International Journal of Dermatology
- Published
- 2026-02-15
- DOI
- https://doi.org/10.1111/ijd.70339
- Primary Topic
- Urticaria and Related Conditions
- Type
- article
- Field-Weighted Citation Impact
- 0.00